Report Library
All Reports
Ovarian Cancer Pulse Survey
May 07, 2014
BioMedTracker will be offering KOL Reports and Physician Pulse Surveys through 2014
for purchase a la carte, or access to all reports and surveys can be purchased as a
subscription to KOL Insight. For more information on KOL Insight subscription, please
email BioMedTracker
or call BioMedTracker Client Services at (858) 200-2357.
We performed a 5-question survey of 18 medical oncologists in the US to gauge current prescribing practices for ovarian cancer treatments and diagnostics and gauge interest in new drug candidates for the treatment of ovarian cancer.
Drugs and drug candidates discussed: Avastin,vintafolide, olaparib
Diagnostics/diagnostic techniques discussed: etarfolatide/folic acid, BRCA mutation testing
To purchase the Ovarian Cancer Pulse Survey, click the link at the top of the page.
For our disclosures, please read the BioMedTracker Research Standards.
We performed a 5-question survey of 18 medical oncologists in the US to gauge current prescribing practices for ovarian cancer treatments and diagnostics and gauge interest in new drug candidates for the treatment of ovarian cancer.
Drugs and drug candidates discussed: Avastin,vintafolide, olaparib
Diagnostics/diagnostic techniques discussed: etarfolatide/folic acid, BRCA mutation testing
To purchase the Ovarian Cancer Pulse Survey, click the link at the top of the page.
For our disclosures, please read the BioMedTracker Research Standards.
| Indications Covered: | Ovarian Cancer |
Additional Resources: